Trial intelligence / Profile preview

Remazolam for Hemodynamics in Hepatectomy

NCT06565715Phase 4Completed

Start
Aug 2024
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam. Started Aug 2024; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on NCT06565715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06565715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call